BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$20.89 USD
+0.09 (0.41%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $20.87 -0.02 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BLFS 20.89 +0.09(0.41%)
Will BLFS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%
EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint
Can BioLife Solutions (BLFS) Climb 30.68% to Reach the Level Wall Street Analysts Expect?
Other News for BLFS
BioLife Solutions Inc (BLFS) Announces Strategic Investment in Pluristyx | BLFS stock news
BioLife Solutions (BLFS) Invests in Pluristyx with Convertible Notes
BioLife Solutions Makes Strategic Investment in Pluristyx | BLFS Stock News
BioLife Solutions purchases $2M of convertible notes in Pluristyx
BioLife Solutions Inc (BLFS) Announces Q2 2025 Financial Results Release Date | BLFS stock news